Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,873 | 428 | 98.2% |
| Education | $125.60 | 9 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,380 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $992.15 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $969.38 | 63 | $0 (2023) |
| Amgen Inc. | $546.46 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $390.10 | 22 | $0 (2022) |
| PFIZER INC. | $377.94 | 19 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $272.51 | 22 | $0 (2024) |
| Amarin Pharma Inc. | $254.13 | 17 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $253.21 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $248.69 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $762.43 | 43 | AstraZeneca Pharmaceuticals LP ($317.95) |
| 2023 | $1,030 | 68 | AstraZeneca Pharmaceuticals LP ($205.71) |
| 2022 | $851.13 | 45 | AstraZeneca Pharmaceuticals LP ($339.20) |
| 2021 | $925.18 | 62 | Janssen Pharmaceuticals, Inc ($236.33) |
| 2020 | $869.20 | 59 | Janssen Pharmaceuticals, Inc ($226.25) |
| 2019 | $915.24 | 61 | GlaxoSmithKline, LLC. ($158.18) |
| 2018 | $907.78 | 55 | Amgen Inc. ($210.99) |
| 2017 | $737.74 | 44 | PFIZER INC. ($138.24) |
All Payment Transactions
437 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.36 | General |
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Endocrinology | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $44.32 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Oncology | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Bone Health | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: RESPIRATORY | ||||||
| 05/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Bone Health | ||||||
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Respiratory | ||||||
| 05/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 753 | 2,534 | $156,695 | $97,686 |
| 2022 | 14 | 910 | 2,454 | $167,117 | $106,644 |
| 2021 | 13 | 866 | 2,421 | $147,284 | $96,030 |
| 2020 | 14 | 966 | 2,642 | $148,358 | $83,667 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 931 | $116,420 | $74,263 | 63.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 79 | 79 | $15,800 | $9,419 | 59.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 107 | $9,416 | $5,616 | 59.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 77 | 78 | $2,730 | $2,377 | 87.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 75 | 76 | $2,660 | $2,138 | 80.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 206 | $6,386 | $1,775 | 27.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 71 | 71 | $1,420 | $1,187 | 83.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 95 | 156 | $780.00 | $738.46 | 94.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 35 | 214 | $642.00 | $78.89 | 12.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 23 | 164 | $328.00 | $56.88 | 17.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 43 | 452 | $113.00 | $36.04 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 841 | $105,175 | $70,988 | 67.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 108 | 108 | $21,250 | $13,267 | 62.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 181 | $15,965 | $10,308 | 64.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 18 | $4,338 | $3,413 | 78.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 85 | 88 | $2,975 | $2,445 | 82.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 80 | 82 | $2,670 | $2,180 | 81.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 84 | 109 | $5,995 | $1,700 | 28.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 57 | 166 | $5,146 | $1,549 | 30.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 114 | 160 | $800.00 | $443.49 | 55.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 21 | 21 | $1,848 | $175.45 | 9.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 25 | 150 | $450.00 | $54.80 | 12.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 24 | 134 | $352.00 | $49.19 | 14.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 12 | $57.00 | $41.32 | 72.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 45 | 384 | $96.00 | $30.52 | 31.8% |
About Dr. Charles Shipman, MD
Dr. Charles Shipman, MD is a General Practice healthcare provider based in Jasper, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508898198.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Shipman, MD has received a total of $6,998 in payments from pharmaceutical and medical device companies, with $762.43 received in 2024. These payments were reported across 437 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,873).
As a Medicare-enrolled provider, Shipman has provided services to 3,495 Medicare beneficiaries, totaling 10,051 services with total Medicare billing of $384,027. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Jasper, AL
- Active Since 07/06/2006
- Last Updated 06/24/2022
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1508898198
Products in Payments
- XARELTO (Drug) $895.59
- FARXIGA (Drug) $787.46
- TRELEGY ELLIPTA (Drug) $773.87
- NUZYRA (Drug) $272.51
- Prolia (Biological) $270.07
- Vascepa (Drug) $254.13
- BREZTRI (Drug) $190.07
- TRINTELLIX (Drug) $189.25
- EVENITY (Biological) $152.17
- JANUVIA (Drug) $147.28
- EUCRISA (Drug) $138.24
- BELSOMRA (Drug) $137.02
- MYRBETRIQ (Drug) $122.81
- AIRSUPRA (Drug) $111.87
- Cologuard Collection Kit (Device) $109.53
- BEVESPI AEROSPHERE (Drug) $98.46
- VRAYLAR (Drug) $98.43
- JARDIANCE (Drug) $98.41
- NURTEC ODT (Drug) $92.84
- STEGLATRO (Drug) $84.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Jasper
Dr. Joshua Foulk, Dmd, DMD
General Practice — Payments: $4,746
Eric Koch, Dds, DDS
General Practice — Payments: $2,986
Dr. Myra Stafford, Dmd, DMD
General Practice — Payments: $1,205
Jenny Doss, Crnp, CRNP
General Practice — Payments: $1,190
Brooke Jordan
General Practice — Payments: $676.30
Dr. Owen Boales, D.m.d, D.M.D
General Practice — Payments: $395.67